BE883998A - Article et composition comprenant une matiere carbonee fortement fluoree pour le traitement des brulures - Google Patents

Article et composition comprenant une matiere carbonee fortement fluoree pour le traitement des brulures

Info

Publication number
BE883998A
BE883998A BE0/201169A BE201169A BE883998A BE 883998 A BE883998 A BE 883998A BE 0/201169 A BE0/201169 A BE 0/201169A BE 201169 A BE201169 A BE 201169A BE 883998 A BE883998 A BE 883998A
Authority
BE
Belgium
Prior art keywords
burns
article
treatment
composition
carbon material
Prior art date
Application number
BE0/201169A
Other languages
English (en)
Inventor
D C White
Original Assignee
Suntech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntech filed Critical Suntech
Publication of BE883998A publication Critical patent/BE883998A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/202—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with halogen atoms, e.g. triclosan, povidone-iodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Materials For Medical Uses (AREA)
BE0/201169A 1979-06-25 1980-06-25 Article et composition comprenant une matiere carbonee fortement fluoree pour le traitement des brulures BE883998A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5204179A 1979-06-25 1979-06-25

Publications (1)

Publication Number Publication Date
BE883998A true BE883998A (fr) 1980-12-29

Family

ID=21975053

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/201169A BE883998A (fr) 1979-06-25 1980-06-25 Article et composition comprenant une matiere carbonee fortement fluoree pour le traitement des brulures

Country Status (8)

Country Link
US (1) US4366169A (fr)
EP (1) EP0031353B1 (fr)
BE (1) BE883998A (fr)
CA (1) CA1161760A (fr)
DE (1) DE3049665T1 (fr)
GB (1) GB2070429B (fr)
IT (1) IT1209229B (fr)
WO (1) WO1981000002A1 (fr)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569784A (en) * 1980-11-17 1986-02-11 Adamantech, Inc. Preparation of a gel having gas transporting capability
US5214214A (en) * 1981-09-08 1993-05-25 The Green Cross Corporation Perfluoro branched alkyl ethers and emulsions
US4879062A (en) * 1981-10-20 1989-11-07 Adamantech, Inc. Preparation of a gel having gas transporting capability
US4490351A (en) * 1982-03-15 1984-12-25 Children's Hospital Medical Center Methods of treating disorders of an eye with liquid perfluorocarbons
US4452818A (en) * 1982-03-19 1984-06-05 Haidt Sterling J Extraocular method of treating the eye with liquid perfluorocarbons
DE3378954D1 (en) * 1982-08-17 1989-02-23 Adamantech Inc Perfluorocarbon emulsions and their preparation and use in therapy
US4742050B1 (en) * 1982-08-17 1994-06-28 Alpha Therapeutic Corp Sensitization of hypoxic tumor cells and control of growth thereof
US4889525A (en) * 1982-08-17 1989-12-26 Adamantech, Inc. Sensitization of hypoxic tumor cells and control of growth thereof
EP0112658B1 (fr) * 1982-11-26 1991-08-07 Children's Hospital Medical Center Dispositif extraoculaire pour le traitement de l'oeil
JPS59130813A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
JPS59130812A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
US4520109A (en) * 1983-03-14 1985-05-28 Sun Tech, Inc. Fluorocarbon tracers and tracing method
US4865836A (en) * 1986-01-14 1989-09-12 Fluoromed Pharmaceutical, Inc. Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
US5514720A (en) * 1986-07-09 1996-05-07 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
US5684050A (en) * 1986-01-24 1997-11-04 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
EP0324802A4 (en) * 1986-09-19 1991-07-24 Chemex Pharmaceuticals, Inc. Method for the treatment of body tissues and the administration of drugs thereto
IL84911A (en) * 1987-12-22 1993-04-04 Yissum Res Dev Co Processes for the preparation of collagen products, and pharmaceutical compositions containing the same
US5171755A (en) * 1988-04-29 1992-12-15 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
US5173298A (en) * 1990-09-27 1992-12-22 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
SE467384B (sv) * 1990-10-24 1992-07-06 Ericsson Telefon Ab L M Saett och kopplingsanordning foer att vid omriktare balansera ingaangs- och/eller utgaangsspaenningsavvikelser
DE4100059C2 (de) * 1991-01-03 1994-08-25 Adatomed Pharma & Med Behandlungsflüssigkeit zum Wiederanlegen (Entfalten) abgelöster Netzhaut an die Aderhaut des Auges
US5200430A (en) * 1991-03-21 1993-04-06 Escalon Ophthalmics, Inc. Debridement of bodily cavities using debridement fluids
US5403575A (en) * 1991-12-12 1995-04-04 Hemagen/Pfc Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
DE4221268C2 (de) * 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
US5350359A (en) * 1992-07-16 1994-09-27 Temple University Of The Commonwealth System Of Higher Education Control, treatment and/or diagnosis of physiological conditions with degassed perfluorocarbon liquid
US5336175A (en) * 1992-10-29 1994-08-09 Mames Robert N Method for the treatment of retinal detachments
FR2710840B1 (fr) * 1993-10-04 1995-12-01 Applic Transferts Technolo Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
RU2088223C1 (ru) * 1994-06-29 1997-08-27 Игорь Вячеславович Белов Антиметастатическое средство
US5865784A (en) 1995-06-07 1999-02-02 Alliance Pharmaceutical Corp. Method of hemodilution facilitated by monitoring oxygenation status
RU2146133C1 (ru) * 1996-07-02 2000-03-10 Далгатов Гимат Далгатович Средство для лечения и профилактики патологического разрастания соединительной ткани в паренхиматозных органах
US5834519A (en) 1996-10-11 1998-11-10 Wayne State University Stabilized gas-supersaturated emulsions and suspensions
US6562358B2 (en) 1998-03-02 2003-05-13 Children's Hospital Medical Center Nontoxic vernix compositions and method of producing
US6333041B1 (en) 1998-03-02 2001-12-25 Children's Hospital Medical Center Nontoxic vernix compositions and method of producing
US6113932A (en) * 1998-03-02 2000-09-05 Children's Hospital Medical Center Nontoxic vernix compositions and method of producing
RU2161122C1 (ru) * 1999-09-10 2000-12-27 Институт молекулярной генетики РАН Способ ускорения окисления оксида азота (no) в гетерогенной среде
US7008535B1 (en) 2000-08-04 2006-03-07 Wayne State University Apparatus for oxygenating wastewater
ATE372124T1 (de) * 2001-02-01 2007-09-15 Hydron Technologies Inc Zusammensetzung und verfahren zur perkutanen superoxygenierung
US7288574B2 (en) * 2001-07-18 2007-10-30 Eckert C Edward Two-phase oxygenated solution and method of use
US7481799B2 (en) * 2002-01-03 2009-01-27 Oxira Medical Inc. Delivery source of oxygen
US8142412B2 (en) * 2002-01-03 2012-03-27 Oxira Medical Inc. Method and apparatus for delivering oxygen and/or other gases to tissue
AU2003226276A1 (en) * 2002-04-05 2003-10-27 David P. Balding Oxygen enriched implant for orthopedic wounds
WO2003086563A2 (fr) 2002-04-11 2003-10-23 Carbomer, Inc. Nouvelles sondes d'imagerie de diabete
US7090829B2 (en) * 2002-04-11 2006-08-15 Carbomer, Inc. Imaging probes
US7959935B2 (en) * 2002-05-03 2011-06-14 Children's Hospital Medical Center Simulated vernix compositions for skin cleansing and other applications
US7357937B2 (en) * 2002-09-24 2008-04-15 Therox, Inc. Perfluorocarbon emulsions with non-fluorinated surfactants
GB0224986D0 (en) * 2002-10-28 2002-12-04 Smith & Nephew Apparatus
US7198179B2 (en) * 2003-02-25 2007-04-03 Therox, Inc. System for storing and dispensing a gas-solubilized product
DE10336841A1 (de) * 2003-08-11 2005-03-17 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut
US7785584B2 (en) * 2003-08-13 2010-08-31 Healthpoint, Ltd. Ointment wound spray
US11298453B2 (en) 2003-10-28 2022-04-12 Smith & Nephew Plc Apparatus and method for wound cleansing with actives
US10413644B2 (en) 2004-04-27 2019-09-17 Smith & Nephew Plc Wound treatment apparatus and method
GB0409446D0 (en) 2004-04-28 2004-06-02 Smith & Nephew Apparatus
US8529548B2 (en) 2004-04-27 2013-09-10 Smith & Nephew Plc Wound treatment apparatus and method
US7753894B2 (en) 2004-04-27 2010-07-13 Smith & Nephew Plc Wound cleansing apparatus with stress
US20060258995A1 (en) * 2004-10-20 2006-11-16 Pendharkar Sanyog M Method for making a reinforced absorbable multilayered fabric for use in medical devices
US9358318B2 (en) * 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
ES2530989T3 (es) 2004-10-20 2015-03-09 Ethicon Inc Hemostático absorbible
CN101257938A (zh) 2005-09-07 2008-09-03 泰科保健集团有限合伙公司 具有真空储存器的伤口敷料
US9017717B2 (en) * 2006-01-16 2015-04-28 Peach Technologies Llc Bandage for facilitating transdermal respiration and healing
US8535691B2 (en) * 2006-02-16 2013-09-17 Peach Technologies, LLC. Perflurochemical treatment process and apparatus
CN101443272A (zh) * 2006-05-15 2009-05-27 弗吉尼亚联邦大学 用于受控和持续产生并输送过氧化物的方法和组合物
CA2654316C (fr) * 2006-06-07 2015-04-07 Trinity Wound Institute, Llc Oxygenotherapie avec ultrasons
EP2252333A4 (fr) * 2008-02-13 2013-07-10 Oxygen Biotherapeutics Inc Traitements de plaie et de tissu à base de gaz
US20110229575A1 (en) * 2008-09-19 2011-09-22 Clauson Gary L Deep immersion flotation therapy for burn victims
US8343515B2 (en) * 2008-11-25 2013-01-01 Oxygen Biotherapeutics, Inc. Perfluorocarbon gel formulations
US20100144597A1 (en) * 2008-12-10 2010-06-10 Ward Kevin R Novel combinatorial approaches to enhancing oxygen transport to tissues
DE102009026718A1 (de) 2009-06-04 2010-04-15 Henkel Ag & Co. Kgaa Hautbehandlung zur Porenverfeinerung II
EP2547201A1 (fr) * 2010-03-19 2013-01-23 Oxygen Biotherapeutics, Inc. Crèmes oculaires aux hydrocarbures perfluorés
RU2446833C2 (ru) * 2010-06-22 2012-04-10 Муниципальное учреждение здравоохранения. Городская Клиническая больница № 11 Способ кожной пластики
EP2587917A4 (fr) * 2010-07-01 2015-05-06 Mtm Res Llc Thérapies au moyen d'émulsions fluorochimiques antifibroblastiques
WO2012044963A2 (fr) * 2010-10-01 2012-04-05 Oxygen Biotherapeutics, Inc. Hydrocarbures perfluorés destinés à être utilisés dans le traitement du prurit
US20130079800A1 (en) * 2011-08-04 2013-03-28 C. Edward Eckert Method for debriding human tissue
DK2747693T3 (en) * 2011-08-26 2018-07-02 On Light Sciences Inc SYSTEM AND PROCEDURE FOR TATTOO REMOVAL
US9669041B2 (en) * 2011-10-27 2017-06-06 Novan, Inc. Nitric oxide releasing bath compositions and methods of using the same
US20140213548A1 (en) * 2013-01-27 2014-07-31 New Jersey Institute Of Technology System and method for hemostatic wound dressing
WO2017025167A1 (fr) 2015-08-11 2017-02-16 Merck Patent Gmbh Combinaison de matériaux
CN112999410B (zh) * 2021-03-05 2022-11-15 江苏君隽生物科技有限公司 含全氟萘烷的纳米氧合水凝胶促愈合敷料及其制法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2968628A (en) * 1958-10-17 1961-01-17 Shulton Inc Propellant composition
US3911138B1 (en) * 1973-02-26 1996-10-29 Childrens Hosp Medical Center Artificial blood and method for supporting oxygen transport in animals
JPS5331209B2 (fr) * 1973-10-05 1978-09-01
US3993581A (en) * 1973-10-05 1976-11-23 The Green Cross Corporation Process for preparing stable oxygen transferable emulsion
FR2280360A1 (fr) * 1974-08-02 1976-02-27 Sogeras Composition cosmetologique oxygenante
US4105798A (en) * 1976-07-19 1978-08-08 Sun Ventures, Inc. Perfluoro polycyclic compounds for use as synthetic blood and perfusion media
US4216233A (en) * 1978-12-06 1980-08-05 Stein Karl N Method for treatment of skin burns in mammals
BE881267A (fr) * 1980-01-18 1980-05-16 Stein Karl N Methode pour le traitement de brulures de la peau chez les mammiferes

Also Published As

Publication number Publication date
EP0031353B1 (fr) 1984-08-08
DE3049665T1 (de) 1982-03-18
CA1161760A (fr) 1984-02-07
EP0031353A1 (fr) 1981-07-08
IT8022637A0 (it) 1980-06-06
GB2070429B (en) 1984-05-02
EP0031353A4 (fr) 1982-07-06
IT1209229B (it) 1989-07-16
US4366169A (en) 1982-12-28
GB2070429A (en) 1981-09-09
DE3049665C2 (fr) 1988-11-24
WO1981000002A1 (fr) 1981-01-08

Similar Documents

Publication Publication Date Title
DE2967577D1 (en) Compositions for the treatment of textile materials and the application thereof
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
JPS5586860A (en) Antistatic composition and surface treatment thereby
GB2066310B (en) Hair-perming process and composition for use therein
ZA796101B (en) New fluorinated products intended for oilproofing and waterproofing treatments of various materials and more particularly of fibrous material
PH13589A (en) Zing sulfadiazine and its use in the treatment of burns
DE2964158D1 (en) Test composition for the determination of triglycerides and its use
SE412867B (sv) Materialkomposition for metallurgisk behandling samt anvendning av densamma
DE2966673D1 (en) Pharmaceutical composition useful for the treatment of hypercholesteremia
DE2964774D1 (en) 2,6-dialkoxybenzamides, process for their preparation, compositions and these compounds for use in the treatment of psychotic disordes
JPS559071A (en) 14*155methylene derivatives of estranes and their manufacture
JPS54125191A (en) Spill control composition and use thereof
IT1115965B (it) Perfezionamento negli apparecchi per l'applicazione controllata di rivestimenti su materiali in foglio
JPS55154973A (en) 1*3*77trialkylxanthine* its manufacture and medical composition
GB2022998B (en) Phermaceutical composition for the treatment of neoplasticand other diseases
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
JPS5580745A (en) Heat treatment of glanular material
GB1541995A (en) Process for the manufacture of sponge iron briquettes
JPS5675499A (en) Novel tenside* its manufacture* its use and composition containing it
JPS5647500A (en) Soap composition and manufacture thereof
FR2305495A1 (fr) Compositions lubrifiantes ameliorant le gonflement des joints d'etancheite
ZA75160B (en) Novel compounds and compositions for treating parkinson's disease
BE842389A (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
RO65965A2 (fr) Composition medicamenteuse pour le traitement d'ulcere gastroduodenel
GB2013189A (en) Process for the preparation of 9 oxobenzomorphans and intermediates for use therein

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SUNTECH INC.

Effective date: 19950630